Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 2/2005

01-06-2005 | Oral Presentation

Molecular profiling of early breast cancer in relation to detection of micrometastases and outcome

Authors: B Naume, T Sørlie

Published in: Breast Cancer Research | Special Issue 2/2005

Login to get access

Excerpt

Molecular profiling of breast cancer by DNA microarrays has been used to classify tumors into five distinct subclasses that show significant differences in clinical outcomes. Of these subclasses, the luminal subtype A is associated with a relatively good prognosis [1‐3]. Detection of disseminated tumor cells (DTC) in bone marrow (BM) can independently predict future metastasis, which was confirmed in our study of 817 early BrCa patients [4]. …
Literature
1.
2.
3.
4.
Wiedswang G, Borgen E, Kåresen R, et al: J Clin Oncol. 2003, 21: 3469-3478. 10.1200/JCO.2003.02.009.CrossRefPubMed
Metadata
Title
Molecular profiling of early breast cancer in relation to detection of micrometastases and outcome
Authors
B Naume
T Sørlie
Publication date
01-06-2005
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 2/2005
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr1078

Other articles of this Special Issue 2/2005

Breast Cancer Research 2/2005 Go to the issue

Oral Presentation

SNPS in putative regulatory loci controlling gene expression in cancer

Poster Presentation

Gene expression profiling in breast cancer challenges the existence of intermediate histological grade

Poster Presentation

Immortalization-associated gene signature in breast cancer

Oral Presentation

Potential mechanisms whereby estrogens induce breast cancer in women

Poster Presentation

Expression of wild-type and mutated TP53in breast carcinomas

Poster Presentation

Brn-3b transcription factor in breast tumourigenesis: regulation of genes associated with growth and migration of cancer cells
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits